Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Geographical distribution of complement receptor type 1 variants and their associated disease risk.

Lucas Sandri T, Adukpo S, Giang DP, Nguetse CN, Antunes Andrade F, Tong HV, Toan NL, Song LH, Elumalai P, Thangaraj K, Valluri VL, Ntoumi F, Meyer CG, Jose de Messias Reason I, Kremsner PG, Velavan TP.

PLoS One. 2017 May 17;12(5):e0175973. doi: 10.1371/journal.pone.0175973. eCollection 2017.

2.

SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.

Hoan NX, Van Tong H, Giang DP, Cuong BK, Toan NL, Wedemeyer H, Bock CT, Kremsner PG, Song LH, Velavan TP.

Oncotarget. 2017 Mar 7;8(10):17127-17139. doi: 10.18632/oncotarget.15083.

3.

Transposition of the Great Arteries in the Developing World: Surgery and Outcomes.

Schidlow DN, Jenkins KJ, Gauvreau K, Croti UA, Giang DT, Konda RK, Novick WM, Sandoval NF, Castañeda A.

J Am Coll Cardiol. 2017 Jan 3;69(1):43-51. doi: 10.1016/j.jacc.2016.10.051.

PMID:
28057249
4.

Association of vitamin D deficiency with hepatitis B virus - related liver diseases.

Hoan NX, Khuyen N, Binh MT, Giang DP, Van Tong H, Hoan PQ, Trung NT, Anh DT, Toan NL, Meyer CG, Kremsner PG, Velavan TP, Song LH.

BMC Infect Dis. 2016 Sep 23;16(1):507.

5.

Interferon-stimulated gene 15 in hepatitis B-related liver diseases.

Hoan NX, Van Tong H, Giang DP, Toan NL, Meyer CG, Bock CT, Kremsner PG, Song LH, Velavan TP.

Oncotarget. 2016 Oct 18;7(42):67777-67787. doi: 10.18632/oncotarget.11955.

6.

Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics.

Rangarajan S, Colby DJ, Truong GL, Huu HN, Thu VT, Quoc BL, Broh TP, Tri DT, Giang DD, Chen M, Zeng Y, West G.

J Virus Erad. 2016 Jan 1;2(1):36-42.

7.

Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing Countries.

Kagan J, Giang DD, Iademarco MF, Phung VT, Lau CY, Quang NN.

Public Health Rep. 2016 May-Jun;131(3):396-403.

8.

Duty Hour Reporting: Conflicting Values in Professionalism.

Byrne JM, Loo LK, Giang DW.

J Grad Med Educ. 2015 Sep;7(3):395-400. doi: 10.4300/JGME-D-14-00763.1.

9.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators.

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.

10.

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group.

Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23.

PMID:
24461574
11.

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis.

Nhu NT, Ha DT, Anh ND, Thu DD, Duong TN, Quang ND, Lan NT, Quyet TV, Tuyen NT, Ha VT, Giang DC, Dung NH, Wolbers M, Farrar J, Caws M.

BMC Infect Dis. 2013 Jan 23;13:31. doi: 10.1186/1471-2334-13-31.

12.

Spatial angular positioning device with three-dimensional magnetoelectric sensors.

Giang DT, Duc PA, Ngoc NT, Hien NT, Duc NH.

Rev Sci Instrum. 2012 Sep;83(9):095006.

PMID:
23020411
13.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

14.

Serum carbohydrate-binding IgM are present in Vietnamese striped catfish (Pangasianodon hypophthalmus) but not in North African catfish (Clarias gariepinus).

Giang DT, Van Driessche E, Beeckmans S.

Dev Comp Immunol. 2012 Feb;36(2):418-32. doi: 10.1016/j.dci.2011.08.012. Epub 2011 Sep 3.

PMID:
21911003
15.

Post-PharmD industry fellowship opportunities and proposed guidelines for uniformity.

Larochelle PA, Giang DK, Silva MA, Kcomt M, Malloy MJ, Kay S, Ku MT.

Am J Pharm Educ. 2009 Feb 19;73(1):20.

16.

Monitoring and improving resident work environment across affiliated hospitals: a call for a national resident survey.

Byrne JM, Loo LK, Giang D.

Acad Med. 2009 Feb;84(2):199-205. doi: 10.1097/ACM.0b013e318193833b.

PMID:
19174665
17.

How different MR imaging criteria relate to the diagnosis of multiple sclerosis and its outcome.

Kido DK, Tong K, Giang DW.

Neuroimaging Clin N Am. 2003 May;13(2):265-72, xi. Review.

PMID:
13677806
18.

Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes.

Patricelli MP, Giang DK, Stamp LM, Burbaum JJ.

Proteomics. 2001 Sep;1(9):1067-71.

PMID:
11990500
19.

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9371-6. Epub 2001 Jul 24.

20.

Resolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy.

Holloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K.

Eur Neurol. 2000;43(3):184-5. No abstract available.

PMID:
10765062

Supplemental Content

Loading ...
Support Center